CTRI/2019/02/017607
Active, not recruiting
未知
Role of platelet rich plasma therapy as an adjuvant in treatment of melasma
Chingshubam Bikash Singh0 sites30 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: L814- Other melanin hyperpigmentation
- Sponsor
- Chingshubam Bikash Singh
- Enrollment
- 30
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed clinically with melasma
- •Patients more than 18 years of age of both sexes
Exclusion Criteria
- •Pregnant and lactating women
- •Women on oral contraceptives
- •Depigmenting treatment in the past 1 month
- •Active facial skin infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse SurgeryPelvic Organ ProlapseNCT05731284University of Alabama at Birmingham60
Completed
Not Applicable
Effect of Platelet-rich plasma treatment of male pattern baldnessAndrogenetic Alopecia.Androgenic alopecia, unspecifiedIRCT2013072814190N1Ahwaz Jundishapur University of Medical Sciences, Vice Chancellor for Research and technology19
Completed
Early Phase 1
Efficacy of Platelet Rich Plasma Injections in Patients With Adhesive Capsulitis of the ShoulderAdhesive Capsulitis of ShoulderAdhesive CapsulitisFrozen ShoulderNCT03951896Ege University32
Completed
Phase 4
Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail SyndromeNail DiseasesNCT04941807Weill Medical College of Cornell University11
Recruiting
Phase 3
The Efficacy of Platelet-Rich-Plasma for prevention of the knee joint cartilage degeneration after anterior cruciate ligament reconstructioPatients after anterior cruciate ligament reconstructionJPRN-jRCTb030200391Yoshitomo Saita80